Acute Myeloid Leukemia (AML)

Dr. Walter's research is interested in identifying novel treatments for patients with myelodysplastic syndromes (MDS) through the discovery of gene mutations that occur in the genomes of hematopoietic cells from patients with MDS.

Dr. Walker received her MD from University of Rochester School of Medicine and Dentistry. She completed an Internal Medicine Residency and a Hematology/Oncology Fellowship at the University of Rochester, New York. She joins us from The Ohio State University, where she served as a Professor in the Department of Internal Medicine, Division of Hematology. Dr. Walker’s clinical interests are in the care of patients with myeloid malignancies, specifically acute myeloid leukemia and myelodysplastic syndromes. She is particularly interested in identifying ways to deliver care that maximizes resource

As a physician–scientist, Dr. Tibes is grateful for the opportunity to advance treatments for people who have cancer through my own groundbreaking research. He has been involved in developing national treatment guidelines for leukemia, and he has been actively engaged in translational research to identify and develop new leukemia treatments over the last few years. Many of these treatments, which directly target the DNA of cancer cells or push leukemia cells to die, were developed in Dr. Tibes' laboratory and have led to clinical trials and U.S. Food and Drug Administration approvals. In his

Dr. Tamari is a board-certified hematologist and oncologist specializing in the use of stem cell transplantation to treat patients with hematologic malignancies (cancers that arise from blood cells). She works as part of a multidisciplinary team of transplantation specialists who treat patients with these diseases. As a clinical researcher, Dr. Tamari's work focuses on identifying risk factors associated with relapse after allogeneic stem cell transplantation for myelodysplastic syndrome and acute muyelogenous leukemia. Together with her colleagues she is developing protocols for early post